SMS Pharma Q1FY18

1. Revenue up 43% at Rs 132 cr v/s Rs 92.5 cr
2. EBITDA up 30% at Rs 19.7 cr v/s Rs 15.2 cr
3. Margins at 14.9% v/s 16.4%
4. PAT up 119 % at Rs 9.2 cr v/s Rs 4.2 cr